CompanyGraph
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleRevenue is $850.33M, above the global median of $548.88M
- FinancialsAltman Z-Score 1.7: grey zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.68%
Annual Rate
SAR 0.50Paid unknown
Payout Ratio
25.0%Sustainable
Payback Period
56.4 yr
Last Ex-Dividend
Jul 8, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.70BSAR720.62M · vs all stocks (USD)
Trailing P/E
14.80xvs Medical Care Facilities peers
Revenue (TTM)
3.19BSAR850.33M · vs all stocks (USD)
Profit Margin
4.33%vs Medical Care Facilities peers
Beta
-0.0170xvs all stocks
52-Week Change
-46.89%vs all stocks
Forward Annual Dividend Yield
1.68%vs all stocks
Market Capitalization
2.70BSAR720.62M · vs all stocks (USD)
Enterprise Value
5.20BSAR1.39B · vs all stocks (USD)
Trailing P/E
14.80xvs Medical Care Facilities peers
Forward P/E
7.91xvs Medical Care Facilities peers
PEG Ratio
-0.3191xvs Medical Care Facilities peers
Price to Sales (TTM)
0.8544xvs Medical Care Facilities peers
Price to Book (MRQ)
1.77xvs Medical Care Facilities peers
Enterprise to Revenue
1.63xvs Medical Care Facilities peers
Enterprise to EBITDA
10.21xvs Medical Care Facilities peers
Gross Margin
31.52%vs Medical Care Facilities peers
Profit Margin
4.33%vs Medical Care Facilities peers
Operating Margin
10.75%vs Medical Care Facilities peers
Return on Assets (TTM)
5.52%vs Medical Care Facilities peers
Return on Equity (TTM)
15.66%vs Medical Care Facilities peers
Revenue (TTM)
3.19BSAR850.33M · vs all stocks (USD)
Revenue per Share (TTM)
34.57SARUpdated Sep 21, 2026Quarterly Revenue Growth
6.90%vs Medical Care Facilities peers
Gross Profit (TTM)
1.66BSAR442.12M · vs all stocks (USD)
EBITDA (TTM)
594.09MSAR158.43M · vs all stocks (USD)
Net Income (TTM)
138.13MSAR36.83M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
73.30%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
714.72MSAR190.59M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
301.88MSAR80.50M · vs all stocks (USD)
Forward Annual Dividend Rate
0.5000SARUpdated Sep 21, 2026Forward Annual Dividend Yield
1.68%vs all stocks
Trailing Annual Dividend Rate
0.5000SARUpdated Sep 21, 2026Trailing Annual Dividend Yield
1.68%vs all stocks
Payout Ratio
25.00%vs Medical Care Facilities peers
Minority Interest (Equity)
55.34MSARFY2025 · Dec 31, 2025Revenue
3.10BSARFY2025 · Dec 31, 2025Cost of Goods Sold
1.94BSARFY2025 · Dec 31, 2025Gross Profit
1.16BSARFY2025 · Dec 31, 2025Operating Income
393.02MSAR104.81M · vs all stocks (USD)
Pre-tax Income
325.49MSARFY2025 · Dec 31, 2025Income Tax Expense
16.03MSARFY2025 · Dec 31, 2025Net Income
309.46MSARFY2025 · Dec 31, 2025EBIT
518.30MSARFY2025 · Dec 31, 2025EBITDA (Income Statement)
639.42MSARFY2025 · Dec 31, 2025Selling, General & Administrative
229.80MSARFY2025 · Dec 31, 2025Other Operating Expenses
24.40MSARFY2025 · Dec 31, 2025Non-operating Interest Expense
192.81MSARFY2025 · Dec 31, 2025EPS (Basic)
3.28SARFY2025 · Dec 31, 2025EPS (Diluted)
3.28SARFY2025 · Dec 31, 2025Basic Shares Outstanding
92.04MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
92.04MSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
-7.58MSARFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00SARFY2025 · Dec 31, 2025Operating Cash Flow
447.32MSARFY2025 · Dec 31, 2025Free Cash Flow
120.07MSARFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
26.30MSARFY2025 · Dec 31, 2025Starting Profit (CF Statement)
325.49MSARFY2025 · Dec 31, 2025Other Non-cash Items
202.31MSARFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-76.38MSARFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-4.11MSARFY2025 · Dec 31, 2025Capital Expenditures
-327.25MSARFY2025 · Dec 31, 2025Net Intangibles (CF)
-2.12MSARFY2025 · Dec 31, 2025Purchase of Investments
-9.00MSARFY2025 · Dec 31, 2025Net Investing Cash Flow
-336.25MSARFY2025 · Dec 31, 2025Long-term Debt Issuance
1.20BSARFY2025 · Dec 31, 2025Long-term Debt Payments
-1.17BSARFY2025 · Dec 31, 2025Common Dividends Paid
-46.02MSARFY2025 · Dec 31, 2025Net Financing Cash Flow
-8.92MSARFY2025 · Dec 31, 2025Shares Outstanding
92.04MSharesUpdated Sep 21, 2026Float Shares
40.81MSharesUpdated Sep 21, 2026% Held by Insiders
54.69%vs all stocks
% Held by Institutions
4.78%vs all stocks
Total Cash (MRQ)
82.54MSAR22.01M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.8970SARUpdated Sep 21, 2026Total Debt (MRQ)
2.48BSAR661.81M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.55xvs Medical Care Facilities peers
Current Ratio (MRQ)
1.55xvs Medical Care Facilities peers
Book Value per Share (MRQ)
16.76SARUpdated Sep 21, 2026Total Assets
5.47BSAR1.46B · vs all stocks (USD)
Total Current Assets
2.26BSARFY2025 · Dec 31, 2025Total Liabilities
3.54BSARFY2025 · Dec 31, 2025Total Non-current Assets
3.21BSARFY2025 · Dec 31, 2025Total Non-current Liabilities
2.08BSARFY2025 · Dec 31, 2025Total Current Liabilities
1.46BSARFY2025 · Dec 31, 2025Cash
26.30MSARFY2025 · Dec 31, 2025Cash & Cash Equivalents
26.30MSARFY2025 · Dec 31, 2025Accounts Receivable
2.02BSARFY2025 · Dec 31, 2025Inventory
65.21MSARFY2025 · Dec 31, 2025Accounts Payable
285.33MSARFY2025 · Dec 31, 2025Short-term Debt
843.22MSARFY2025 · Dec 31, 2025Other Current Liabilities
4.95MSARFY2025 · Dec 31, 2025Long-term Debt
1.70BSARFY2025 · Dec 31, 2025Common Stock (Book)
920.40MSARFY2025 · Dec 31, 2025Retained Earnings
725.61MSARFY2025 · Dec 31, 2025Total Shareholders' Equity
1.93BSAR514.06M · vs all stocks (USD)
52-Week Low
28.66SARUpdated Sep 21, 202652-Week High
59.20SARUpdated Sep 21, 202652-Week Change
-46.89%vs all stocks
Beta
-0.0170xvs all stocks
50-Day MA
31.58SARUpdated Sep 21, 2026200-Day MA
33.47SARUpdated Sep 21, 2026Avg 10-Day Volume
300.16KSharesUpdated Sep 21, 2026Avg 30-Day Volume
445.87KSharesUpdated Sep 21, 2026Diluted EPS (TTM)
2.00SARUpdated Sep 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
High OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-Deceleration
Cash covers reported profit and gross profit is up, with margins high and growth slowing.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.7: grey zoneSignificant
Altman Z-Score: 1.70
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Revenue is $850.33M, above the global median of $548.88MNotable
Revenue (USD): 850,327,872.699Global Median: 548,883,780.48
Levered free cash flow is $80.5M, above the global median of $18.73MNotable
Levered free cash flow (USD): 80,503,472.948Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Wuxi New Hongtai Electrical Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Topre Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
Zhuzhou Tianqiao Crane Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sichuan Tianyi Comheart Telecom Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
RP Optical Lab Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Anhui Huilong Agricultural Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Jiangyin Huaxin Precision Technology Corporation
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Jiangxi Rimag Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlow
Sanchuan Wisdom Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingFlow
Taiwan Semiconductor Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Stantec Inc.
3 interpretationsHigh OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-DecelerationClose Below 40W SMA With ProfitabilityMulti-Year Revenue, Profit, And Income Growth
Stryker Corporation
3 interpretationsHigh OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-DecelerationClose Below 40W SMA With ProfitabilityMulti-Year Revenue, Profit, And Income Growth
Groupe Dynamite Inc.
3 interpretationsHigh OCF-to-NI With Multi-Year Gross-Profit Growth and Elevated-Margin-With-DecelerationClose Below 40W SMA With ProfitabilityMulti-Year Revenue, Profit, And Income Growth